Related Experiment Videos
The risks of warfarin use in the elderly.
Luke R Bereznicki1, Gregory M Peterson, Shane L Jackson
1Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia.
Expert Opinion on Drug Safety
|April 14, 2006
Summary
Warfarin use in elderly patients for stroke prevention is rising. Careful patient selection, low-dose initiation, education, and close monitoring are crucial for safe and effective anticoagulant management in this population.
Area of Science:
- Geriatrics
- Pharmacology
- Cardiology
Background:
- Warfarin use is increasing in elderly patients for stroke prevention in chronic atrial fibrillation.
- Elderly patients experience greater benefits but also higher risks and management challenges with warfarin therapy.
- Oral anticoagulants are essential for managing atrial fibrillation, with warfarin remaining a primary option.
Purpose of the Study:
- To highlight the challenges of warfarin management in the elderly.
- To propose improvements in clinical systems for safer warfarin use.
- To emphasize strategies for optimizing anticoagulant therapy in older adults.
Main Methods:
- Review of current clinical practices and challenges in elderly warfarin management.
- Identification of key areas for improvement in patient selection and therapy initiation.
- Discussion of patient education, monitoring, and self-management strategies.
Main Results:
- Warfarin benefits are substantial in the elderly, but so are risks and management complexities.
- Current clinical systems require enhancement to address the therapeutic dilemma.
- Specific strategies are needed for safe and effective anticoagulation in older adults.
Conclusions:
- Improved clinical systems are necessary for safe warfarin use in the elderly.
- Key strategies include careful patient selection, low-dose initiation, and comprehensive patient education.
- Close monitoring, patient involvement in management, and ongoing therapy review are vital for optimizing outcomes.